<DOC>
	<DOC>NCT01067079</DOC>
	<brief_summary>This study will evaluate the immunogenicity of rabies vaccine at 13 months, 3 year and 5 years after initial vaccination, administered in two different post-exposure vaccination schedules</brief_summary>
	<brief_title>Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure Regimen</brief_title>
	<detailed_description />
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male and Female subjects who received complete vaccine series in accordance to the designated vaccination schedule in the previous M49P8 study Any disease condition, that in the opinion of investigator may interfere with subjects ability to participate in the study. Receipt of additional doses of rabies vaccine after completion of initial vaccine series. For additional entry criteria please refer to protocol.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Rabies vaccine</keyword>
	<keyword>Long-term Immunogenicity</keyword>
</DOC>